Cellectar Biosciences (CLRB) Change in Cash (2010 - 2025)

Cellectar Biosciences has reported Change in Cash for 16 years, with the latest figure at $641744.0 in Q4 2025.

• Quarterly Change in Cash rose 105.85% year-over-year to $641744.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$10.1 million (down 173.54% YoY) and the FY2025 annual result came in at -$10.1 million, down 173.54% from the prior year.
• Change in Cash fell to $641744.0 in Q4 2025 per CLRB's latest filing, from $1.5 million in the prior quarter.
• Over five years, Change in Cash peaked at $30.5 million in Q1 2024 and troughed at -$14.2 million in Q2 2024.
• A 5-year average of -$2.2 million and a median of -$5.4 million in 2022 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2023 and 2024: Change in Cash slumped 552.73% in 2023, then surged 524.1% in 2024.
• Over 5 years, Change in Cash stood at -$4.6 million in 2021, then jumped by 144.84% to $2.1 million in 2022, then plunged by 552.73% to -$9.4 million in 2023, then decreased by 16.49% to -$11.0 million in 2024, then soared by 105.85% to $641744.0 in 2025.
• According to Business Quant data, Change in Cash over the past three periods registered $641744.0, $1.5 million, and -$2.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.